메뉴 건너뛰기




Volumn 142, Issue 6, 2012, Pages

Effectiveness of hepatitis B treatment in clinical practice

Author keywords

Antiviral Therapy; Efficacy; Interferon; Nucleos(t)ide Analogues; Screening

Indexed keywords

ADEFOVIR; ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; EMTRICITABINE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; VIRUS DNA;

EID: 84860304268     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.01.044     Document Type: Article
Times cited : (130)

References (74)
  • 1
    • 77950611229 scopus 로고    scopus 로고
    • Institute of Medicine recommendations for the prevention and control of hepatitis B and C
    • A.E. Mitchell, H.M. Colvin, R. Palmer Beasley Institute of Medicine recommendations for the prevention and control of hepatitis B and C Hepatology 51 2010 729 733
    • (2010) Hepatology , vol.51 , pp. 729-733
    • Mitchell, A.E.1    Colvin, H.M.2    Palmer Beasley, R.3
  • 2
    • 80051688850 scopus 로고    scopus 로고
    • The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference
    • A. Hatzakis, S. Wait, J. Bruix The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference J Viral Hepat 18 Suppl 1 2011 1 16
    • (2011) J Viral Hepat , vol.18 , Issue.SUPPL. 1 , pp. 1-16
    • Hatzakis, A.1    Wait, S.2    Bruix, J.3
  • 3
    • 33748338297 scopus 로고    scopus 로고
    • Hepatitis B vaccines
    • World Health Organization
    • World Health Organization Hepatitis B vaccines Wkly Epidemiol Rec 79 2004 253 264
    • (2004) Wkly Epidemiol Rec , vol.79 , pp. 253-264
  • 4
    • 33748114343 scopus 로고    scopus 로고
    • The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
    • J.F. Perz, G.L. Armstrong, L.A. Farrington The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
    • (2006) J Hepatol , vol.45 , pp. 529-538
    • Perz, J.F.1    Armstrong, G.L.2    Farrington, L.A.3
  • 5
    • 79952220557 scopus 로고    scopus 로고
    • Hepatitis B virus in the United States: Infection, exposure, and immunity rates in a nationally representative survey
    • G.N. Ioannou Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey Ann Intern Med 154 2011 319 328
    • (2011) Ann Intern Med , vol.154 , pp. 319-328
    • Ioannou, G.N.1
  • 6
    • 33646492332 scopus 로고    scopus 로고
    • Screening for chronic hepatitis B among Asian/Pacific islander populations-New York City, 2005
    • CDC
    • CDC Screening for chronic hepatitis B among Asian/Pacific islander populations-New York City, 2005 Morb Mortal Wkly Rep 55 2006 505 509
    • (2006) Morb Mortal Wkly Rep , vol.55 , pp. 505-509
  • 7
    • 21244447705 scopus 로고    scopus 로고
    • Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    • G.K. Lau, T. Piratvisuth, K.X. Luo Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N Engl J Med 352 2005 2682 2695
    • (2005) N Engl J Med , vol.352 , pp. 2682-2695
    • Lau, G.K.1    Piratvisuth, T.2    Luo, K.X.3
  • 8
    • 4544239807 scopus 로고    scopus 로고
    • Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
    • P. Marcellin, G.K. Lau, F. Bonino Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 2004 1206 1217
    • (2004) N Engl J Med , vol.351 , pp. 1206-1217
    • Marcellin, P.1    Lau, G.K.2    Bonino, F.3
  • 9
    • 19944428132 scopus 로고    scopus 로고
    • Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial
    • H.L. Janssen, M. van Zonneveld, H. Senturk Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial Lancet 365 2005 123 129
    • (2005) Lancet , vol.365 , pp. 123-129
    • Janssen, H.L.1    Van Zonneveld, M.2    Senturk, H.3
  • 10
    • 13444309139 scopus 로고    scopus 로고
    • A randomized, controlled trial of combination therapy for chronic hepatitis B: Comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone
    • H.L. Chan, N.W. Leung, A.Y. Hui A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone Ann Intern Med 142 2005 240 250
    • (2005) Ann Intern Med , vol.142 , pp. 240-250
    • Chan, H.L.1    Leung, N.W.2    Hui, A.Y.3
  • 11
    • 0033592764 scopus 로고    scopus 로고
    • Lamivudine as initial treatment for chronic hepatitis B in the United States
    • J.L. Dienstag, E.R. Schiff, T.L. Wright Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1999 1256 1263
    • (1999) N Engl J Med , vol.341 , pp. 1256-1263
    • Dienstag, J.L.1    Schiff, E.R.2    Wright, T.L.3
  • 12
    • 0037468421 scopus 로고    scopus 로고
    • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    • P. Marcellin, T.T. Chang, S.G. Lim Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808 816
    • (2003) N Engl J Med , vol.348 , pp. 808-816
    • Marcellin, P.1    Chang, T.T.2    Lim, S.G.3
  • 13
    • 21244455293 scopus 로고    scopus 로고
    • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    • S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B N Engl J Med 352 2005 2673 2681
    • (2005) N Engl J Med , vol.352 , pp. 2673-2681
    • Hadziyannis, S.J.1    Tassopoulos, N.C.2    Heathcote, E.J.3
  • 14
    • 37349120537 scopus 로고    scopus 로고
    • Telbivudine versus lamivudine in patients with chronic hepatitis B
    • C.L. Lai, E. Gane, Y.F. Liaw Telbivudine versus lamivudine in patients with chronic hepatitis B N Engl J Med 357 2007 2576 2588
    • (2007) N Engl J Med , vol.357 , pp. 2576-2588
    • Lai, C.L.1    Gane, E.2    Liaw, Y.F.3
  • 15
    • 33644822860 scopus 로고    scopus 로고
    • Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    • C.L. Lai, D. Shouval, A.S. Lok Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B N Engl J Med 354 2006 1011 1020
    • (2006) N Engl J Med , vol.354 , pp. 1011-1020
    • Lai, C.L.1    Shouval, D.2    Lok, A.S.3
  • 16
    • 33644818518 scopus 로고    scopus 로고
    • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
    • T.T. Chang, R.G. Gish, R. de Man A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B N Engl J Med 354 2006 1001 1010
    • (2006) N Engl J Med , vol.354 , pp. 1001-1010
    • Chang, T.T.1    Gish, R.G.2    De Man, R.3
  • 17
    • 57349095400 scopus 로고    scopus 로고
    • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
    • P. Marcellin, E.J. Heathcote, M. Buti Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B N Engl J Med 359 2008 2442 2455
    • (2008) N Engl J Med , vol.359 , pp. 2442-2455
    • Marcellin, P.1    Heathcote, E.J.2    Buti, M.3
  • 18
    • 48549107919 scopus 로고    scopus 로고
    • Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b
    • E.H. Buster, H.J. Flink, Y. Cakaloglu Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b Gastroenterology 135 2008 459 467
    • (2008) Gastroenterology , vol.135 , pp. 459-467
    • Buster, E.H.1    Flink, H.J.2    Cakaloglu, Y.3
  • 19
    • 77952725714 scopus 로고    scopus 로고
    • Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
    • V.W. Wong, G.L. Wong, K.K. Yan Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 2010 1945 1953
    • (2010) Hepatology , vol.51 , pp. 1945-1953
    • Wong, V.W.1    Wong, G.L.2    Yan, K.K.3
  • 20
    • 66449121130 scopus 로고    scopus 로고
    • Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a
    • e1-4
    • P. Marcellin, F. Bonino, G.K. Lau Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a Gastroenterology 136 2009 2169 2179 e1-4
    • (2009) Gastroenterology , vol.136 , pp. 2169-2179
    • Marcellin, P.1    Bonino, F.2    Lau, G.K.3
  • 21
    • 33745921497 scopus 로고    scopus 로고
    • A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B
    • M. Zeng, Y. Mao, G. Yao A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B Hepatology 44 2006 108 116
    • (2006) Hepatology , vol.44 , pp. 108-116
    • Zeng, M.1    Mao, Y.2    Yao, G.3
  • 22
    • 84860315818 scopus 로고    scopus 로고
    • Long-term telbivudine therapy with effective viral control results in resolution of liver fibrosis and inflammation achieving treatment goals in patients with chronic hepatitis B (abstr)
    • J.L. Hou, D.Z. Xu, S. Guangeng Long-term telbivudine therapy with effective viral control results in resolution of liver fibrosis and inflammation achieving treatment goals in patients with chronic hepatitis B (abstr) Hepatology Suppl 2011 1048A
    • (2011) Hepatology , Issue.SUPPL.
    • Hou, J.L.1    Xu, D.Z.2    Guangeng, S.3
  • 23
    • 10744225554 scopus 로고    scopus 로고
    • Long-term safety of lamivudine treatment in patients with chronic hepatitis B
    • A.S. Lok, C.L. Lai, N. Leung Long-term safety of lamivudine treatment in patients with chronic hepatitis B Gastroenterology 125 2003 1714 1722
    • (2003) Gastroenterology , vol.125 , pp. 1714-1722
    • Lok, A.S.1    Lai, C.L.2    Leung, N.3
  • 24
    • 51349107091 scopus 로고    scopus 로고
    • Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    • P. Marcellin, T.T. Chang, S.G. Lim Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B Hepatology 48 2008 750 758
    • (2008) Hepatology , vol.48 , pp. 750-758
    • Marcellin, P.1    Chang, T.T.2    Lim, S.G.3
  • 25
    • 79953311247 scopus 로고    scopus 로고
    • Long term (4 year) efficacy and safety of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients (HBeAg+) with chronic hepatitis B (study 103)
    • J. Heathcote Long term (4 year) efficacy and safety of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients (HBeAg+) with chronic hepatitis B (study 103) Hepatology 52 Suppl 2010 556A 557A
    • (2010) Hepatology , vol.52 , Issue.SUPPL.
    • Heathcote, J.1
  • 26
    • 77955485392 scopus 로고    scopus 로고
    • Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B
    • J.G. Reijnders, M.J. Perquin, N. Zhang Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B Gastroenterology 139 2010 491 498
    • (2010) Gastroenterology , vol.139 , pp. 491-498
    • Reijnders, J.G.1    Perquin, M.J.2    Zhang, N.3
  • 27
    • 75449093009 scopus 로고    scopus 로고
    • Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
    • H.W. Lee, H.J. Lee, J.S. Hwang Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B Hepatology 51 2010 415 421
    • (2010) Hepatology , vol.51 , pp. 415-421
    • Lee, H.W.1    Lee, H.J.2    Hwang, J.S.3
  • 28
    • 0037468406 scopus 로고    scopus 로고
    • Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    • S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 348 2003 800 807
    • (2003) N Engl J Med , vol.348 , pp. 800-807
    • Hadziyannis, S.J.1    Tassopoulos, N.C.2    Heathcote, E.J.3
  • 29
    • 33845671388 scopus 로고    scopus 로고
    • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
    • S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 2006 1743 1751
    • (2006) Gastroenterology , vol.131 , pp. 1743-1751
    • Hadziyannis, S.J.1    Tassopoulos, N.C.2    Heathcote, E.J.3
  • 30
    • 0032499913 scopus 로고    scopus 로고
    • A one-year trial of lamivudine for chronic hepatitis B Asia Hepatitis Lamivudine Study Group
    • C.L. Lai, R.N. Chien, N.W. Leung A one-year trial of lamivudine for chronic hepatitis B Asia Hepatitis Lamivudine Study Group N Engl J Med 339 1998 61 68
    • (1998) N Engl J Med , vol.339 , pp. 61-68
    • Lai, C.L.1    Chien, R.N.2    Leung, N.W.3
  • 31
    • 70350089249 scopus 로고    scopus 로고
    • Trends in waiting list registration for liver transplantation for viral hepatitis in the United States
    • W.R. Kim, N.A. Terrault, R.A. Pedersen Trends in waiting list registration for liver transplantation for viral hepatitis in the United States Gastroenterology 137 2009 1680 1686
    • (2009) Gastroenterology , vol.137 , pp. 1680-1686
    • Kim, W.R.1    Terrault, N.A.2    Pedersen, R.A.3
  • 32
    • 33751514752 scopus 로고    scopus 로고
    • Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
    • S.M. Lin, M.L. Yu, C.M. Lee Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma J Hepatol 46 2007 45 52
    • (2007) J Hepatol , vol.46 , pp. 45-52
    • Lin, S.M.1    Yu, M.L.2    Lee, C.M.3
  • 33
    • 0029893146 scopus 로고    scopus 로고
    • Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
    • C. Niederau, T. Heintges, S. Lange Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B N Engl J Med 334 1996 1422 1427
    • (1996) N Engl J Med , vol.334 , pp. 1422-1427
    • Niederau, C.1    Heintges, T.2    Lange, S.3
  • 34
    • 61449187479 scopus 로고    scopus 로고
    • Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: A meta-analysis
    • Y.F. Yang, W. Zhao, Y.D. Zhong Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis J Viral Hepat 16 2009 265 271
    • (2009) J Viral Hepat , vol.16 , pp. 265-271
    • Yang, Y.F.1    Zhao, W.2    Zhong, Y.D.3
  • 35
    • 53549107488 scopus 로고    scopus 로고
    • Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
    • J.J. Sung, K.K. Tsoi, V.W. Wong Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma Aliment Pharmacol Ther 28 2008 1067 1077
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 1067-1077
    • Sung, J.J.1    Tsoi, K.K.2    Wong, V.W.3
  • 36
    • 19544391413 scopus 로고    scopus 로고
    • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    • Y.F. Liaw, J.J. Sung, W.C. Chow Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
    • (2004) N Engl J Med , vol.351 , pp. 1521-1531
    • Liaw, Y.F.1    Sung, J.J.2    Chow, W.C.3
  • 37
    • 77955306935 scopus 로고    scopus 로고
    • Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
    • G.V. Papatheodoridis, P. Lampertico, S. Manolakopoulos Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review J Hepatol 53 2010 348 356
    • (2010) J Hepatol , vol.53 , pp. 348-356
    • Papatheodoridis, G.V.1    Lampertico, P.2    Manolakopoulos, S.3
  • 38
    • 0037221907 scopus 로고    scopus 로고
    • Histological outcome during long-term lamivudine therapy
    • J.L. Dienstag, R.D. Goldin, E.J. Heathcote Histological outcome during long-term lamivudine therapy Gastroenterology 124 2003 105 117
    • (2003) Gastroenterology , vol.124 , pp. 105-117
    • Dienstag, J.L.1    Goldin, R.D.2    Heathcote, E.J.3
  • 39
    • 77956639159 scopus 로고    scopus 로고
    • Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
    • T.T. Chang, Y.F. Liaw, S.S. Wu Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
    • (2010) Hepatology , vol.52 , pp. 886-893
    • Chang, T.T.1    Liaw, Y.F.2    Wu, S.S.3
  • 40
    • 34247538953 scopus 로고    scopus 로고
    • Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
    • F. Bonino, P. Marcellin, G.K. Lau Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B Gut 56 2007 699 705
    • (2007) Gut , vol.56 , pp. 699-705
    • Bonino, F.1    Marcellin, P.2    Lau, G.K.3
  • 41
    • 80054724912 scopus 로고    scopus 로고
    • Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
    • H.L. Chan, A. Thompson, M. Martinot-Peignoux Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report J Hepatol 55 2011 1121 1131
    • (2011) J Hepatol , vol.55 , pp. 1121-1131
    • Chan, H.L.1    Thompson, A.2    Martinot-Peignoux, M.3
  • 42
    • 0032869876 scopus 로고    scopus 로고
    • Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Asian Hepatitis Lamivudine Trial Group
    • R.N. Chien, Y.F. Liaw, M. Atkins Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Asian Hepatitis Lamivudine Trial Group Hepatology 30 1999 770 774
    • (1999) Hepatology , vol.30 , pp. 770-774
    • Chien, R.N.1    Liaw, Y.F.2    Atkins, M.3
  • 43
    • 58649096155 scopus 로고    scopus 로고
    • 2-Year GLOBE trial results: Telbivudine is superior to lamivudine in patients with chronic hepatitis B
    • Y.F. Liaw, E. Gane, N. Leung 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B Gastroenterology 136 2009 486 495
    • (2009) Gastroenterology , vol.136 , pp. 486-495
    • Liaw, Y.F.1    Gane, E.2    Leung, N.3
  • 44
    • 73149085984 scopus 로고    scopus 로고
    • Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
    • C.M. Lange, J. Bojunga, W.P. Hofmann Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function Hepatology 50 2009 2001 2006
    • (2009) Hepatology , vol.50 , pp. 2001-2006
    • Lange, C.M.1    Bojunga, J.2    Hofmann, W.P.3
  • 45
    • 79959551969 scopus 로고    scopus 로고
    • Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
    • Y.F. Liaw, M. Raptopoulou-Gigi, H. Cheinquer Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study Hepatology 54 2011 91 100
    • (2011) Hepatology , vol.54 , pp. 91-100
    • Liaw, Y.F.1    Raptopoulou-Gigi, M.2    Cheinquer, H.3
  • 46
    • 78751491184 scopus 로고    scopus 로고
    • Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
    • Y.F. Liaw, I.S. Sheen, C.M. Lee Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease Hepatology 53 2011 62 72
    • (2011) Hepatology , vol.53 , pp. 62-72
    • Liaw, Y.F.1    Sheen, I.S.2    Lee, C.M.3
  • 47
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: Update 2009
    • A.S. Lok, B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 48
    • 51049107683 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
    • Y.F. Liaw, N. Leung, J.H. Kao Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 2008 263 283
    • (2008) Hepatol Int , vol.2 , pp. 263-283
    • Liaw, Y.F.1    Leung, N.2    Kao, J.H.3
  • 49
    • 58149296156 scopus 로고    scopus 로고
    • EASL Clinical Practice Guidelines: Management of chronic hepatitis B
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
    • (2009) J Hepatol , vol.50 , pp. 227-242
  • 50
    • 33644858331 scopus 로고    scopus 로고
    • Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
    • U.H. Iloeje, H.I. Yang, J. Su Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 2006 678 686
    • (2006) Gastroenterology , vol.130 , pp. 678-686
    • Iloeje, U.H.1    Yang, H.I.2    Su, J.3
  • 51
    • 13844322073 scopus 로고    scopus 로고
    • Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
    • M.W. Yu, S.H. Yeh, P.J. Chen Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men J Natl Cancer Inst 97 2005 265 272
    • (2005) J Natl Cancer Inst , vol.97 , pp. 265-272
    • Yu, M.W.1    Yeh, S.H.2    Chen, P.J.3
  • 52
    • 29944436855 scopus 로고    scopus 로고
    • Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    • C.J. Chen, H.I. Yang, J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
    • (2006) JAMA , vol.295 , pp. 65-73
    • Chen, C.J.1    Yang, H.I.2    Su, J.3
  • 53
    • 80053577592 scopus 로고    scopus 로고
    • Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma
    • e2
    • C.F. Chen, W.C. Lee, H.I. Yang Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma Gastroenterology 141 2011 1240 1248 e2
    • (2011) Gastroenterology , vol.141 , pp. 1240-1248
    • Chen, C.F.1    Lee, W.C.2    Yang, H.I.3
  • 54
    • 34247478067 scopus 로고    scopus 로고
    • Chronic hepatitis B virus carriers in the immunotolerant phase of infection: Histologic findings and outcome
    • T. Andreani, L. Serfaty, D. Mohand Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome Clin Gastroenterol Hepatol 5 2007 636 641
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 636-641
    • Andreani, T.1    Serfaty, L.2    Mohand, D.3
  • 55
    • 34548303664 scopus 로고    scopus 로고
    • Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
    • C.K. Hui, N. Leung, S.T. Yuen Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase Hepatology 46 2007 395 401
    • (2007) Hepatology , vol.46 , pp. 395-401
    • Hui, C.K.1    Leung, N.2    Yuen, S.T.3
  • 56
    • 55549091704 scopus 로고    scopus 로고
    • The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: Association with liver disease progression A prospective cohort study
    • G. Zacharakis, J. Koskinas, S. Kotsiou The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression A prospective cohort study J Hepatol 49 2008 884 891
    • (2008) J Hepatol , vol.49 , pp. 884-891
    • Zacharakis, G.1    Koskinas, J.2    Kotsiou, S.3
  • 57
    • 0036110833 scopus 로고    scopus 로고
    • Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
    • M. Martinot-Peignoux, N. Boyer, M. Colombat Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers J Hepatol 36 2002 543 546
    • (2002) J Hepatol , vol.36 , pp. 543-546
    • Martinot-Peignoux, M.1    Boyer, N.2    Colombat, M.3
  • 58
    • 70649104668 scopus 로고    scopus 로고
    • Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa
    • E.H. Buster, B.E. Hansen, G.K. Lau Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa Gastroenterology 137 2009 2002 2009
    • (2009) Gastroenterology , vol.137 , pp. 2002-2009
    • Buster, E.H.1    Hansen, B.E.2    Lau, G.K.3
  • 59
    • 77950609092 scopus 로고    scopus 로고
    • Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage
    • I.C. Wu, C.L. Lai, S.H. Han Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage Hepatology 51 2010 1185 1189
    • (2010) Hepatology , vol.51 , pp. 1185-1189
    • Wu, I.C.1    Lai, C.L.2    Han, S.H.3
  • 60
    • 34447259615 scopus 로고    scopus 로고
    • The natural history and treatment of chronic hepatitis B: A critical evaluation of standard treatment criteria and end points
    • C.L. Lai, M.F. Yuen The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points Ann Intern Med 147 2007 58 61
    • (2007) Ann Intern Med , vol.147 , pp. 58-61
    • Lai, C.L.1    Yuen, M.F.2
  • 61
    • 84860292208 scopus 로고    scopus 로고
    • The efficacy and tolerability of pegylated interferon-alpha-2a in chronic hepatitis B: A multicenter clinical experience
    • [Epub ahead of print]
    • D. Ratnam, A. Dev, T. Nguyen The efficacy and tolerability of pegylated interferon-alpha-2a in chronic hepatitis B: a multicenter clinical experience J Gastroenterol Hepatol 2011 Dec 14 [Epub ahead of print]
    • (2011) J Gastroenterol Hepatol
    • Ratnam, D.1    Dev, A.2    Nguyen, T.3
  • 62
    • 84863011075 scopus 로고    scopus 로고
    • A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice
    • M.C. Tsai, C.M. Lee, K.W. Chiu A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice J Antimicrob Chemother 67 2012 696 699
    • (2012) J Antimicrob Chemother , vol.67 , pp. 696-699
    • Tsai, M.C.1    Lee, C.M.2    Chiu, K.W.3
  • 63
    • 78649631236 scopus 로고    scopus 로고
    • Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
    • W. Chotiyaputta, C. Peterson, F.A. Ditah Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B J Hepatol 54 2011 12 18
    • (2011) J Hepatol , vol.54 , pp. 12-18
    • Chotiyaputta, W.1    Peterson, C.2    Ditah, F.A.3
  • 64
    • 79957481330 scopus 로고    scopus 로고
    • Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
    • C. Hongthanakorn, W. Chotiyaputta, K. Oberhelman Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice Hepatology 53 2011 1854 1863
    • (2011) Hepatology , vol.53 , pp. 1854-1863
    • Hongthanakorn, C.1    Chotiyaputta, W.2    Oberhelman, K.3
  • 65
    • 34547810965 scopus 로고    scopus 로고
    • Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California
    • C.A. Wu, S.Y. Lin, S.K. So Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California Asian Pac J Cancer Prev 8 2007 127 134
    • (2007) Asian Pac J Cancer Prev , vol.8 , pp. 127-134
    • Wu, C.A.1    Lin, S.Y.2    So, S.K.3
  • 66
    • 33947512072 scopus 로고    scopus 로고
    • Knowledge, attitudes, and behaviors of hepatitis B screening and vaccination and liver cancer risks among Vietnamese Americans
    • G.X. Ma, S.E. Shive, C.Y. Fang Knowledge, attitudes, and behaviors of hepatitis B screening and vaccination and liver cancer risks among Vietnamese Americans J Health Care Poor Underserved 18 2007 62 73
    • (2007) J Health Care Poor Underserved , vol.18 , pp. 62-73
    • Ma, G.X.1    Shive, S.E.2    Fang, C.Y.3
  • 67
    • 33847781872 scopus 로고    scopus 로고
    • Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants
    • G.X. Ma, C.Y. Fang, S.E. Shive Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants J Immigr Minor Health 9 2007 213 220
    • (2007) J Immigr Minor Health , vol.9 , pp. 213-220
    • Ma, G.X.1    Fang, C.Y.2    Shive, S.E.3
  • 68
    • 79955417384 scopus 로고    scopus 로고
    • Management of chronic hepatitis B virus (HBV) infection by primary care physicians in urban hospital and clinics in New York City
    • [abstract 984]
    • H. Pollack, K. Wan, T. Miyoshi Management of chronic hepatitis B virus (HBV) infection by primary care physicians in urban hospital and clinics in New York City Hepatology 46 Suppl 2007 676A [abstract 984]
    • (2007) Hepatology , vol.46 , Issue.SUPPL.
    • Pollack, H.1    Wan, K.2    Miyoshi, T.3
  • 69
    • 67449151609 scopus 로고    scopus 로고
    • The Jade Ribbon Campaign: A model program for community outreach and education to prevent liver cancer in Asian Americans
    • S.D. Chao, E.T. Chang, P.V. Le The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans J Immigr Minor Health 11 2009 281 290
    • (2009) J Immigr Minor Health , vol.11 , pp. 281-290
    • Chao, S.D.1    Chang, E.T.2    Le, P.V.3
  • 70
    • 79955414239 scopus 로고    scopus 로고
    • Are primary care clinicians knowledgeable about screening for chronic hepatitis B infection?
    • Presented at the 30th annual meeting of the Society of General Internal Medicine (SGIM)
    • M. Dulay, A. Baron, C. Lai Are primary care clinicians knowledgeable about screening for chronic hepatitis B infection? Presented at the 30th annual meeting of the Society of General Internal Medicine (SGIM) J Gen Intern Med 22 Suppl 1 2007 747 753
    • (2007) J Gen Intern Med , vol.22 , Issue.SUPPL. 1 , pp. 747-753
    • Dulay, M.1    Baron, A.2    Lai, C.3
  • 71
    • 43549097763 scopus 로고    scopus 로고
    • Family physicians' knowledge and screening of chronic hepatitis and liver cancer
    • J.M. Ferrante, D.G. Winston, P.H. Chen Family physicians' knowledge and screening of chronic hepatitis and liver cancer Fam Med 40 2008 345 351
    • (2008) Fam Med , vol.40 , pp. 345-351
    • Ferrante, J.M.1    Winston, D.G.2    Chen, P.H.3
  • 72
    • 79955461172 scopus 로고    scopus 로고
    • Is chronic hepatitis B being undertreated in the United States?
    • C. Cohen, S.D. Holmberg, B.J. McMahon Is chronic hepatitis B being undertreated in the United States? J Viral Hepat 18 2011 377 383
    • (2011) J Viral Hepat , vol.18 , pp. 377-383
    • Cohen, C.1    Holmberg, S.D.2    McMahon, B.J.3
  • 73
    • 80053465684 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B virus infection in resource-constrained settings: Expert panel consensus
    • S.T. Wiersma, B. McMahon, J.M. Pawlotsky Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus Liver Int 31 2011 755 761
    • (2011) Liver Int , vol.31 , pp. 755-761
    • Wiersma, S.T.1    McMahon, B.2    Pawlotsky, J.M.3
  • 74
    • 0042265556 scopus 로고    scopus 로고
    • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
    • C.T. Wai, J.K. Greenson, R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
    • (2003) Hepatology , vol.38 , pp. 518-526
    • Wai, C.T.1    Greenson, J.K.2    Fontana, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.